JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhagat, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhagat, B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 157, Issue 1, 74-80, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


THE INFLUENCE OF SYMPATHETIC NERVOUS ACTIVITY ON CARDIAC CATECHOLAMINE LEVELS

B. Bhagat 1

1 Department of Pharmacology, College of Medicine, Howard University, Washington, D. C.

Norepinephrine, a natural transmitter, is stored in vesicles of sympathetic nerve endings. Small amounts of this amine are released continuously into the circulation to maintain tonic activity; increasing amounts are released in response to sympathetic nerve stimulation. Cardiac catecholamine concentrations remained unaltered even in the face of vigorous sympathetic activity produced by 1) prolonged sympathetic nerve stimulation, 2) exposure to cold for 6 hr and 3) administration of histamine or beta-tetrahydronaphthylamine. Such maintenance of endogenous amine levels was not possible when synthesis of norepinephrine was inhibited by the tyrosine hydroxylase inhibitor, agr-methyltyrosine. In this case tissue catecholamine levels were reduced. This reduction, however, was antagonized by pretreatment of animals with ganglionic blocking agents, adrenergic neuron blocking agents or monoamine oxidase inhibitors or by destruction of the brain and spinal cord. The usual elevation in catecholamine levels after inhibition of monoamine oxidase or ganglionic blockade was not observed when synthesis was inhibited by agr-methyltyrosine. The common factor in all these experiments is the inhibition of spontaneous release due to tonic impulses in sympathetic nerve fibers. This suggests that once synthesis is inhibited, tonic release of catecholamine is sufficient to cause a gradual depletion of the amine. This depletion after agr-methyltyrosine was increased when sympathetic nerve activity was increased by various procedures. Since agr-methyltyrosine did not affect the accumulation of H3-norepinephrine in the rat heart, these findings suggest that catecholamine synthesis is indeed increased in response to increased sympathetic nerve activity which helps to maintain normal levels of tissue catscholamine. Thus the present study shows that maintenance of endogenous amine levels is based largely on adjustment of local norepinephrine synthesis which is presumably regulated by activity in the sympathetic nerves.

Submitted on December 2, 1966
Accepted on February 21, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.